Symphogen
Martin Alsted Bendz has extensive experience in the field of lab automation and antibody discovery at Symphogen, where employment commenced in September 2005. Currently serving as a Lab Automation Specialist, Martin focuses on programming, optimizing, and developing solid automation setups to enhance the antibody discovery process in 24-384 well plate formats. Responsibilities include keeping abreast of relevant literature, evaluating new equipment, and maintaining existing tools. Previously, Martin held the position of Technician at Symphogen, contributing to various lab operations.
This person is not in the org chart
Symphogen
3 followers
Symphogen is a clinical-stage antibody oncology focused company with a differentiated product pipeline and significant commercial opportunities. Inspired by nature, led by science and driven by people, we passionately strive to make that discovery that may have great effect on the lives of patients, their families, and their caregivers. Based on our monoclonal antibody (mAb) research platform, we create differentiated mAb and mAb mixture products candidates. Our pre-clinical and clinical pipeline is well suited for a precision-medicine approach by addressing well-defined, biomarker-selected patient populations. We are headquartered in Denmark with operations in the US.